Arming adoptively transferred T-cells with drug-loaded nanoparticles for cancer immunotherapy
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Biological Engineering, February 2016.
Main Author: | Zheng, Yiran, Ph. D. Massachusetts Institute of Technology |
---|---|
Other Authors: | Darrell J. Irvine. |
Format: | Thesis |
Language: | eng |
Published: |
Massachusetts Institute of Technology
2016
|
Subjects: | |
Online Access: | http://hdl.handle.net/1721.1/103697 |
Similar Items
-
Microfluidic models for adoptive cell-mediated cancer immunotherapies
by: Adriani, Giulia, et al.
Published: (2018) -
Delivering safer immunotherapies for cancer
by: Milling, Lauren Elizabeth, et al.
Published: (2018) -
In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes
by: Zheng, Yiran, et al.
Published: (2014) -
Pathogen boosted adoptive cell transfer immunotherapy to treat solid tumors
by: Xin, Gang, et al.
Published: (2017) -
Integrin-targeted cancer immunotherapy
by: Kwan, Byron H. (Byron Hua)
Published: (2016)